Asymmetrex: Funding, Investors & Team (Oct 2026)
Asymmetrex® is a private, for-profit biotechnology company that specializes in technologies for stem cell medicine. Asymmetrex®'s founder, President and CEO is a leading authority on the unique properties of adult tissue stem cells. Asymmetrex holds a rich portfolio of intellectual property for technologies that address major barriers to success in regenerative medicine. These include patented methods for mass-producing adult tissue stem cells and their differentiated derivatives; counting adult tissue stem cells; engineering adult tissues stem cells; and evaluating effects of new drug candidates on adult tissue stem cells. Current products include renewable adult tissue stem cells strains for research applications and exclusive licensing of technologies for specific fields of use. In 2023, the company introduced the first-ever rapid-counting tissue stem cell calculators. The calculators are available free online at https://asymmetrex.com/stem-cell-counting-center. This first generation of free tissue stem cell calculators are applicable to commonly used human HSC-containing preparations and human adipose MSC-containing preparations. These and next-generation stem cell calculators will be used to develop the first commercial automated electronic tissue stem cell counters.
Asymmetrex has raised $1.8M across 1 funding round on record, the most recent an undisclosed round of $1.8M announced in Oct 2024.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Asymmetrex Company Profile and Key Stats
Latest funding round on record: Oct 2024.
Asymmetrex Funding Rounds
Asymmetrex Founders and Leadership Team
Contact details for the Asymmetrex team: 1 of 1 has an email address on file.
Start 14-day free trial →Asymmetrex Funding Compared to Other Biotechnology Startups
Asymmetrex's latest round of $1.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Asymmetrex in Biotechnology and Boston
Companies Similar to Asymmetrex
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Asymmetrex Funding FAQs
What does Asymmetrex do?
Asymmetrex® is a private, for-profit biotechnology company that specializes in technologies for stem cell medicine. Asymmetrex®'s founder, President and CEO is a leading authority on the unique properties of adult tissue stem cells. Asymmetrex holds a rich portfolio of intellectual property for technologies that address major barriers to success in regenerative medicine. These include patented methods for mass-producing adult tissue stem cells and their differentiated derivatives; counting adult tissue stem cells; engineering adult tissues stem cells; and evaluating effects of new drug candidates on adult tissue stem cells. Current products include renewable adult tissue stem cells strains for research applications and exclusive licensing of technologies for specific fields of use. In 2023, the company introduced the first-ever rapid-counting tissue stem cell calculators. The calculators are available free online at https://asymmetrex.com/stem-cell-counting-center. This first generation of free tissue stem cell calculators are applicable to commonly used human HSC-containing preparations and human adipose MSC-containing preparations. These and next-generation stem cell calculators will be used to develop the first commercial automated electronic tissue stem cell counters.
How much funding has Asymmetrex raised?
Asymmetrex has raised $1.8M across 1 round on record. The most recent is an undisclosed round of $1.8M announced in Oct 2024.
When did Asymmetrex last raise funding?
Asymmetrex's most recent funding round on record is an undisclosed round of $1.8M, announced in Oct 2024.
Who founded Asymmetrex?
FundedIQ lists James L Sherley (Founder) at Asymmetrex.
Where is Asymmetrex headquartered?
Asymmetrex is based in Boston, Massachusetts, United States.
How many employees does Asymmetrex have?
Asymmetrex is in the 1-10 employee band.
How does Asymmetrex's funding compare to other Biotechnology startups?
Asymmetrex's latest round of $1.8M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Asymmetrex Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Asymmetrex is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.